Outcomes of COVID-19 in patients with CLL: a multicenter international experience von Mato, Anthony R., Roeker, Lindsey E., Lamanna, Nicole, Allan, John N., Leslie, Lori, Pagel, John M., Patel, Krish, Osterborg, Anders, Wojenski, Daniel, Kamdar, Manali, Huntington, Scott F., Davids, Matthew S., Brown, Jennifer R., Antic, Darko, Jacobs, Ryan, Ahn, Inhye E., Pu, Jeffrey, Isaac, Krista M., Barr, Paul M., Ujjani, Chaitra S., Geyer, Mark B., Berman, Ellin, Zelenetz, Andrew D., Malakhov, Nikita, Furman, Richard R., Koropsak, Michael, Bailey, Neil, Hanson, Lotta, Perini, Guilherme F., Ma, Shuo, Ryan, Christine E., Wiestner, Adrian, Portell, Craig A., Shadman, Mazyar, Chong, Elise A., Brander, Danielle M., Sundaram, Suchitra, Seddon, Amanda N., Seymour, Erlene, Patel, Meera, Martinez-Calle, Nicolas, Munir, Talha, Walewska, Renata, Broom, Angus, Walter, Harriet, El-Sharkawi, Dima, Parry, Helen, Wilson, Matthew R., Patten, Piers E.M., Hernández-Rivas, José-Ángel, Miras, Fatima, Fernández Escalada, Noemi, Ghione, Paola, Nabhan, Chadi, Lebowitz, Sonia, Bhavsar, Erica, López-Jiménez, Javier, Naya, Daniel, Garcia-Marco, Jose Antonio, Skånland, Sigrid S., Cordoba, Raul, Eyre, Toby A.

Volltext

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies von Roeker, Lindsey E., Eyre, Toby A., Thompson, Meghan C., Lamanna, Nicole, Coltoff, Alexander R., Davids, Matthew S., Baker, Peter O., Leslie, Lori, Rogers, Kerry A., Allan, John N., Cordoba, Raul, Lopez-Garcia, Alberto, Antic, Darko, Pagel, John M., Martinez-Calle, Nicolas, García-Marco, José Antonio, Hernández‐Rivas, Jose‐Ángel, Miras, Fatima, Coombs, Catherine C., Österborg, Anders, Hansson, Lotta, Seddon, Amanda N., López Jiménez, Javier, Wilson, Matthew R., El-Sharkawi, Dima, Wojenski, Daniel, Ma, Shuo, Munir, Talha, Valenciano, Susana, Seymour, Erlene, Barr, Paul M., Pu, Jeffrey, Patten, Piers E.M., Perini, Guilherme F., Huntington, Scott F., Parry, Helen, Sundaram, Suchitra, Skarbnik, Alan, Kamdar, Manali, Jacobs, Ryan, Walter, Harriet, Walewska, Renata, Broom, Angus, Lebowitz, Sonia, Isaac, Krista M., Portell, Craig A., Ahn, Inhye E., Ujjani, Chaitra S., Shadman, Mazyar, Skånland, Sigrid S., Chong, Elise A., Mato, Anthony R.

Volltext

Pirtobrutinib in Post-cBTKi CLL/SLL: ~30 Months Follow-up and Subgroup Analysis With/Without Prior BCL2i from the Phase 1/2 BRUIN Study von Woyach, Jennifer A., Brown, Jennifer R., Ghia, Paolo, Roeker, Lindsey E., Patel, Krish, Eyre, Toby A., Munir, Talha, Lech-Maranda, Ewa, Lamanna, Nicole, Tam, Constantine S., Seymour, John F., Tessoulin, Benoit, Shah, Nirav N., Ujjani, Chaitra S, Fakhri, Bita, Coombs, Catherine C., Flinn, Ian W., Patel, Manish, Nasta, Sunita D., Cohen, Jonathon B., Alencar, Alvaro J., Cheah, Chan Y., Ma, Shuo, Rhodes, Joanna M., Jagadeesh, Deepa, Zinzani, Pier Luigi, Osterborg, Anders, Izutsu, Koji, Tsai, Donald E., Abada, Paolo, Balbas, Minna, Li, Jian, Ruppert, Amy S., Jurczak, Wojciech, Wierda, William G.

Volltext

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL von Mato, AR, Roeker, LE, Eyre, TA, Nabhan, C, Lamanna, N, Hill, BT, Brander, DM, Barr, PM, Lansigan, F, Cheson, BD, Singavi, AK, Yazdy, MS, Shah, NN, Allan, JN, Bhavsar, EB, Rhodes, J, Kennard, K, Schuster, SJ, Williams, AM, Skarbnik, AP, Goy, AH, Goodfriend, JM, Dorsey, C, Coombs, CC, Tuncer, H, Ujjani, CS, Jacobs, R, Winter, AM, Pagel, JM, Bailey, N, Schuh, A, Shadman, M, Sitlinger, A, Weissbrot, H, Muralikrishnan, S, Zelenetz, A, Kirkwood, AA, Fox, CP

Volltext bestellen

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy von Ujjani, Chaitra, Mato, Anthony, Hill, Brian T, Allan, John N, Lansigan, Frederick, Jacobs, Ryan, Skarbnik, Alan, Tuncer, Hande, Pagel, John, Brander, Danielle, Cheson, Bruce, Barr, Paul, Roeker, Lindsey E, Pu, Jeffrey, Shah, Nirav N, Goy, Andre, Schuster, Stephen J, Lamanna, Nicole, Sehgal, Alison, Tam, Constantine S, Shadman, Mazyar

Volltext

High Efficacy and Low Toxicity of MB-106, a Third Generation CD20 Targeted CAR-T for Treatment of Relapsed/Refractory B-NHL and CLL von Shadman, Mazyar, Yeung, Cecilia CS, Redman, Mary, Lee, Sang Yun, Lee, Dong Hoon, Ra, Susan, Ujjani, Chaitra S, Dezube, Bruce J, Poh, Christina, Warren, Edus H., Chapuis, Aude G., Green, Damian J., Cowan, Andrew J., Cassaday, Ryan D., Kiem, Hans-Peter, Gauthier, Jordan, Turtle, Cameron J., Lynch, Ryan C., Smith, Stephen D., Gopal, Ajay K., Maloney, David G., Till, Brian G.

Volltext

225 - High Efficacy and Low Toxicity of MB-106, a Third Generation CD20 Targeted CAR-T for Treatment of Relapsed/Refractory B-NHL and CLL von Shadman, Mazyar, Yeung, Cecilia CS, Redman, Mary, Lee, Sang Yun, Lee, Dong Hoon, Ra, Susan, Ujjani, Chaitra S, Dezube, Bruce J, Poh, Christina, Warren, Edus H., Chapuis, Aude G., Green, Damian J., Cowan, Andrew J., Cassaday, Ryan D., Kiem, Hans-Peter, Gauthier, Jordan, Turtle, Cameron J., Lynch, Ryan C., Smith, Stephen D., Gopal, Ajay K., Maloney, David G., Till, Brian G.

Volltext